Search Ontology:
ChEBI
N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
- Term ID
- CHEBI:132887
- Synonyms
-
- beta-D-GalNAc6dH2-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- beta-D-GalpNAc6dH2-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
- C6 aldehyde asialo GM2
- N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-beta-D-galacto-hexodialdo-1,5-pyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
- N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine
- Definition
- A glycotriaosylceramide having N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl as the triaosyl component.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Phenotype where environments contain N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Phenotype modified by environments containing N-acetyl-beta-D-galacto-hexodialdo-1,5-pyranosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Human Disease Model